TwySHE - An Mhealth Peer-navigator Intervention to Increase PrEP and Contraceptive Use
Launched by UNIVERSITY OF COLORADO, DENVER · Feb 24, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The TwySHE clinical trial is designed to find out if a special program called a "mhealth peer navigator intervention" can help young women at risk for HIV in Zambia use preventive medication called PrEP. This trial focuses on female university students between the ages of 18 and 24 who have not been diagnosed with HIV but report having multiple risk factors for the virus. Participants in the program will be paired with a trained peer navigator who will provide support, education, and assistance in accessing PrEP and other sexual and reproductive health services.
To join the trial, women must be current university students aged 18 to 24 and have reported at least three behaviors that put them at risk for HIV. Participants will complete surveys at the beginning of the study, and again at six and twelve months, to help researchers understand how effective the program is in promoting the use of PrEP. The study is currently recruiting eligible participants, and it aims to improve health behaviors and outcomes for young women at risk of HIV.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female
- • Aged 18 to 24 years
- • Current university student
- • Not diagnosed with HIV
- • Self-report of 3 more HIV risk factors
- Exclusion Criteria:
- • Male
- • Less than 18 years of age
- • Greater than 24 years of age
- • Diagnosed with HIV
- • Less than 3 self-reported HIV risk behaviors
- • Not a university student
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lusaka, , Zambia
Patients applied
Trial Officials
Karen M Hampanda, PhD
Principal Investigator
University of Colorado, Denver
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported